Healthcare -
Biotechnology - NASDAQ - US
$ 0.356
-49.1 %
$ 129 M
Market Cap
-0.48
P/E
LXRX - TOTAL LIABILITIES & EQUITY
Total Liabilities & Equity LXRX - Lexicon Pharmaceuticals, Inc.
229 M
LAST VALUE
46.86%
2 YEAR CAGR
17.06%
5 YEAR CAGR
8.47%
10 YEAR CAGR